EV/EBITDA
-16.70
+0.06+0.36%
9 min ago
Summary
- As of March 12, 2025, TARS EV/EBITDA is -16.70, with a rise of +0.06 (+0.36%) during the most recent trading day.
- Over the past year, TARS EV/EBITDA has dropped by -9.46 (-130.66%).
- TARS EV/EBITDA is now -642.22% below its all-time high of -2.25.
Performance
TARS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TARS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +0.4% | -0.3% | -0.3% |
| 1 m1 month | +10.1% | -10.0% | -10.0% |
| 3 m3 months | -14.7% | -3.4% | -7.8% |
| 6 m6 months | -119.5% | +62.7% | +48.6% |
| ytdytd | +15.1% | -15.0% | -14.9% |
| 1 y1 year | -130.7% | +87.3% | +53.9% |
| 5 y5 years | - | - | - |
TARS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -11.2% | -18.80 | +11.2% | |
| 3 m | 3-month | -14.56 | -14.7% | -20.42 | +18.2% |
| 6 m | 6-month | -7.44 | -124.5% | -20.42 | +18.2% |
| 1 y | 1-year | -5.23 | -219.3% | -20.42 | +18.2% |
| 3 y | 3-year | -2.25 | -642.2% | -20.42 | +18.2% |
| 5 y | 5-year | -2.25 | -642.2% | -126.62 | +86.8% |
| alltime | all time | -2.25 | -642.2% | -126.62 | +86.8% |
Tarsus Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.70(-15.1%) |
| 2024 | -19.66(+420.1%) |
| 2023 | -3.78(-34.8%) |
| Date | Value |
|---|---|
| 2022 | -5.80(-75.5%) |
| 2021 | -23.65(-5.4%) |
| 2020 | -25.00 |
FAQ
- What is Tarsus Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?
- What is TARS EV/EBITDA year-to-date change?
- What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?
What is Tarsus Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of TARS is -16.70
What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high EV/EBITDA is -2.25
What is TARS EV/EBITDA year-to-date change?
Tarsus Pharmaceuticals EV/EBITDA has changed by +2.96 (+15.06%) since the beginning of the year
What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, TARS EV/EBITDA has changed by -9.46 (-130.66%)